IPP Bureau
Syngene International invests in peptide laboratory in Bengaluru
By IPP Bureau - October 16, 2025
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
BASF’s Personal Care business launches Ameriflor Calm
By IPP Bureau - October 16, 2025
Sourced and formulated in the United States, Ameriflor Calm is derived from plants grown on regenerative organic certified farms and is manufactured at a site that uses 100% renewable electricity
BASF launches combined vitamin A and D3 product for animal nutrition
By IPP Bureau - October 16, 2025
Lutavit A/D3 1000/200 NXT provides a combination of vitamin A and vitamin D3 in one formulation
Nouryon launches sustainable technologies for cleaning ingredient at SEPAWA Congress
By IPP Bureau - October 16, 2025
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
Merck KGaA to acquire chromatography business of JSR Life Sciences
By IPP Bureau - October 16, 2025
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
Merck’s DOR/ISL regimen shows minimal impact on weight and lipids in phase 3 HIV studies
By IPP Bureau - October 16, 2025
These findings follow positive Phase 3 results presented earlier this year
Corning and SGD Pharma inaugurate glass tubing facility in Telangana
By IPP Bureau - October 14, 2025
The new plant will manufacture high-quality Type I borosilicate glass tubing
Hikal launches HPAPI laboratory at Integrated Innovation Centre, Pune
By IPP Bureau - October 14, 2025
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements
Fredun Pharmaceuticals launches India's first pure Jain dog biscuit
By IPP Bureau - October 14, 2025
This innovation reinforces Fredun's commitment to creating a 360 degree pet wellness ecosystem
Mankind Pharma MD Rajeev Juneja appointed new president of PHDCCI
By IPP Bureau - October 14, 2025
Anil Gupta has been appointed as the Senior Vice President, and Sanjay Singhania has taken charge as the Vice President of PHDCCI
BioMed X launches women’s health R&D accelerator ‘XFem labs’ in Germany
By IPP Bureau - October 14, 2025
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
FDA approves AbbVie’s Upadacitinib for treatment of inflammatory bowel disease
By IPP Bureau - October 14, 2025
Updated indication expands treatment options for patients with ulcerative colitis and Crohn’s disease when tumor necrosis factor (TNF) blockers are clinically inadvisable
Gilead and Kite to transform cancer care with new data at ESMO 2025
By IPP Bureau - October 14, 2025
The study met its primary endpoint, demonstrating a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to chemotherapy
AbbVie showcases breakthrough ADC hard-to-treat cancers data at ESMO 2025
By IPP Bureau - October 14, 2025
New results from telisotuzumab adizutecan (Temab-A) and ABBV-706 demonstrate continued progress in AbbVie's antibody-drug conjugate (ADC) portfolio targeting difficult-to-treat cancers
